Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part two

Trends in Parasitology

Volumn 24, Issue 8, 2008, Pages 371-377

  Miró, Guadalupe ^a   Cardoso, Luis ^b   Pennisi, Maria Grazia ^c   Oliva, Gaetano ^d   Baneth, Gad ^e  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ENROFLOXACIN; KETOCONAZOLE; LEISHMANIA VACCINE; LEISHMUNE; MEGLUMINE ANTIMONATE; METRONIDAZOLE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SPIRAMYCIN;

DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOPATHOLOGY; HUMAN; INFECTION PREVENTION; INFECTION RISK; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PARASITE TRANSMISSION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; VACCINE PRODUCTION; VECTOR CONTROL; ZOONOSIS;

ANIMALS; DOG DISEASES; DOGS; HUMANS; INSECT BITES AND STINGS; INSECT VECTORS; LEISHMANIA INFANTUM; LEISHMANIASIS; PSYCHODIDAE; ZOONOSES;

CANIS FAMILIARIS; LEISHMANIA INFANTUM; PHLEBOTOMINAE;

EID: 47849109026     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2008.05.003     Document Type: Review

References (71)

1. Baneth G., et al. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 24 (2008) 324-330
2. Solano-Gallego L., et al. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J. Clin. Microbiol. 39 (2001) 560-563
3. Oliva G., et al. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naïve dogs exposed to three consecutive transmission seasons. J. Clin. Microbiol. 44 (2006) 1318-1322
4. Slappendel R.J. Canine leishmaniasis. A review based on 95 cases in The Netherlands. Vet. Q. 10 (1988) 1-16
5. Gomes Y.M., et al. Diagnosis of canine visceral leishmaniasis: biotechnological advances. Vet. J. 175 (2008) 45-52
6. Strauss-Ayali D., et al. Polymerase chain reaction using noninvasively obtained samples, for the detection of Leishmania infantum DNA in dogs. J. Infect. Dis. 189 (2004) 1729-1733
7. Barrouin-Melo S.M., et al. Can spleen aspirations be safely used for the parasitological diagnosis of canine visceral leishmaniosis? A study on asymptomatic and polysymptomatic animals. Vet. J. 171 (2006) 331-339
8. Chargui N., et al. Increase of canine leishmaniasis in a previously low-endemicity area in Tunisia. Parasite 14 (2007) 247-251
9. Alvar J., et al. Canine leishmaniasis. Adv. Parasitol. 57 (2004) 1-88
10. Reis A.B., et al. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Res. Vet. Sci. 81 (2006) 68-75
11. Giunchetti R.C., et al. Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 121 (2008) 23-33
12. Saridomichelakis M.N., et al. Evaluation of lymph node and bone marrow cytology in the diagnosis of canine leishmaniasis (Leishmania infantum) in symptomatic and asymptomatic dogs. Am. J. Trop. Med. Hyg. 73 (2005) 82-86
13. Moreira M.A., et al. Comparison of parasitological, immunological and molecular methods for the diagnosis of leishmaniasis in dogs with different clinical signs. Vet. Parasitol. 145 (2007) 245-252
14. Tafuri W.L., et al. An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues. J. Immunol. Methods 292 (2004) 17-23
15. Lachaud L., et al. Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. J. Clin. Microbiol. 40 (2002) 210-215
16. Nasereddin A., et al. Serological survey with PCR validation for canine visceral leishmaniasis in northern Palestine. J. Parasitol. 92 (2006) 178-183
17. Francino O., et al. Advantages of a real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet. Parasitol. 137 (2006) 214-221
18. Manna L., et al. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Vet. J 177 (2008) 279-282
19. Ferreira Ede C., et al. Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations. Vet. Parasitol. 146 (2007) 235-241
20. Porrozzi R., et al. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin. Vaccine Immunol. 14 (2007) 544-548
21. Scalone A., et al. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorent assay. Vet. Parasitol. 104 (2002) 275-285
22. Mettler M., et al. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescence-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infection in dogs. J. Clin. Microbiol. 43 (2005) 5515-5519
23. Baneth G., and Aroch I. Canine leishmaniasis: a clinical and diagnostic challenge. Vet. J. 175 (2008) 14-15
24. Noli C., and Auxilia S.T. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet. Dermatol. 16 (2005) 213-232
25. Plevraki K., et al. Effects of allopurinol treatment on the progression of chronic nephritis in canine leishmaniosis (Leishmania infantum). J. Vet. Intern. Med. 20 (2006) 228-233
26. Koutinas A.F., et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet. Parasitol. 98 (2001) 247-261
27. Guarga J.L., et al. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 88 (2002) 13-20
28. Ikeda-Garcia F.A., et al. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet. Parasitol. 143 (2007) 254-259
29. Bianciardi P., et al. The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis. Parasitol. Res. 93 (2004) 486-492
30. Pennisi M.G., et al. Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin. Vet. Rec. 156 (2005) 346-349
31. Croft S.L., et al. Drug resistance in leishmaniasis. Clin. Microbiol. Rev. 19 (2006) 111-126
32. Borja-Cabrera G.P., et al. Long lasting protection against canine kala-azar using FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 20 (2002) 3277-3284
33. ® vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine. Vet. Parasitol. 141 (2006) 1-8
34. Lemesre J.L., et al. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
35. Mayrink W., et al. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infection in dogs. Mem. Inst. Oswaldo Cruz 91 (1996) 695-697
36. Lasri S., et al. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. Vet. Res. 30 (1999) 441-449
37. Mohebali M., et al. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine 22 (2004) 4097-4100
38. Giunchetti R.C., et al. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine 26 (2007) 623-638
39. da Silva V.O., et al. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 19 (2001) 1082-1092
40. ® vaccine blocks the transmission of canine visceral leishmaniasis. Absence of Leishmania parasite in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23 (2005) 4805-4810
41. Borja-Cabrera G.P., et al. Effective immunotherapy against canine visceral leishmaniasis with the FML- vaccine. Vaccine 22 (2004) 2234-2243
42. Santos F.N., et al. Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine. Vaccine 25 (2007) 6176-6190
43. de Oliveira Mendes C., et al. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis. Vaccine 21 (2003) 2589-2597
44. Lemesre J.L., et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomized efficacy field trial. Vaccine 25 (2007) 4223-4234
45. Gradoni L., et al. Failure of a multi-subunit recombinant leishmania vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Vaccine 23 (2005) 5245-5251
46. Ramiro M.J., et al. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 21 (2003) 2474-2484
47. Rafati S., et al. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinase type I and II of L. infantum. Vaccine 23 (2005) 3716-3725
48. Rodríguez-Cortés A., et al. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Vaccine 25 (2007) 7962-7971
49. Killick-Kendrick R., et al. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis. Med. Vet. Entomol. 11 (1997) 105-111
50. Molina R., et al. Evaluation of a topical solution containing 65% permethrin against the sandfly (Phlebotomus perniciosus) in dogs. Vet. Ther. 2 (2001) 261-267
51. Molina R., et al. Evaluation of a spray of permethrin and pyriproxyfen for the protection of dogs against Phlebotomus perniciosus. Vet. Rec. 159 (2006) 206-209
52. Miró G., et al. Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog. Vet. Parasitol. 143 (2007) 375-379
53. Otranto D., et al. Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kenneled dogs in an endemic area. Vet. Parasitol. 144 (2007) 270-278
54. Maroli M., et al. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med. Vet. Entomol. 15 (2001) 358-363
55. David J.R., et al. Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei. Mem. Inst. Oswaldo Cruz 96 (2001) 839-847
56. Gavgani A.S., et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visveral leishmaniosis in Iranian children: a matched-cluster randomised trial. Lancet 360 (2002) 374-379
57. Foglia Manzillo V., et al. Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs. Vet. Parasitol. 142 (2006) 142-145
58. Saridomichelakis M.N., et al. Periodic administration of allopurinol is not effective for the prevention of canine leishmaniosis (Leishmania infantum) in endemic areas. Vet. Parasitol. 130 (2005) 199-205
59. Alexander B., and Maroli M. Control of phlebotomine sandflies. Med. Vet. Entomol. 17 (2003) 1-18
60. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35 (2005) 1169-1180
61. Werneck G.L., et al. Multilevel modeling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol. Infect. 135 (2006) 195-201
62. Margonari C., et al. Epidemiology of visceral leishmaniasis through spatial analysis, in Belo Horizonte municipality, state of Minas Gerais, Brazil. Mem. Inst. Oswaldo Cruz 101 (2006) 31-38
63. Gavgani A.S., et al. Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum. Am. J. Trop. Med. Hyg. 67 (2002) 511-515
64. Acedo Sánchez C., et al. Leishmaniasis eco-epidemiology in the Alpujarra region (Granada province, southern Spain). Int. J. Parasitol. 26 (1996) 303-310
65. Papadopoulou C., et al. Human and canine leishmaniasis in asymptomatic and symptomatic population in northwestern Greece. J. Infect. 50 (2005) 53-60
66. Courtenay O., et al. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 186 (2002) 1314-1320
67. Moreira E.D., et al. Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission. Vet. Parasitol. 122 (2004) 245-252
68. Palatnik-de-Sousa C.B., et al. Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am. J. Trop. Med. Hyg. 65 (2001) 510-517
69. Nunes C.M., et al. Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil. Vet. Parasitol. 153 (2008) 19-23
70. Dujardin J.C. Risk factors in the spread of leishmaniases: towards integrated monitoring?. Trends Parasitol. 22 (2006) 4-6
71. Ferroglio E., et al. Evaluation of an ELISA rapid device for the serological diagnosis of Leishmania infantum infection in dog as compared with immunofluorescence assay and western blot. Vet. Parasitol. 144 (2007) 162-166